Department of Radiology and Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States.
Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 177 Stockholm, Sweden.
ACS Appl Bio Mater. 2022 Jun 20;5(6):2643-2663. doi: 10.1021/acsabm.2c00109. Epub 2022 May 11.
Albumin-based hydrogels offer unique benefits such as biodegradability and high binding affinity to various biomolecules, which make them suitable candidates for biomedical applications. Here, we report a non-immunogenic photocurable human serum-based (HSA) hydrogel synthesized by methacryloylation of human serum albumin by methacrylic anhydride (MAA). We used matrix-assisted laser desorption ionization-time-of-flight mass spectrometry, liquid chromatography-tandem mass spectrometry, as well as size exclusion chromatography to evaluate the extent of modification, hydrolytic and enzymatic degradation of methacrylated albumin macromer and its cross-linked hydrogels. The impacts of methacryloylation and cross-linking on alteration of inflammatory response and toxicity were evaluated using brain-derived HMC3 macrophages and Ex-Ovo chick chorioallantoic membrane assay. Results revealed that the lysines in HSA were the primary targets reacting with MAA, though modification of cysteine, threonine, serine, and tyrosine, with MAA was also confirmed. Both methacrylated HSA and its derived hydrogels were nontoxic and did not induce inflammatory pathways, while significantly reducing macrophage adhesion to the hydrogels; one of the key steps in the process of foreign body reaction to biomaterials. Cytokine and growth factor analysis showed that albumin-based hydrogels demonstrated anti-inflammatory response modulating cellular events in HMC3 macrophages. Ex-Ovo results also confirmed the biocompatibility of HSA macromer and hydrogels along with slight angiogenesis-modulating effects. Photocurable albumin hydrogels may be used as a non-immunogenic platform for various biomedical applications including passivation coatings.
基于白蛋白的水凝胶具有独特的优势,如生物可降解性和对各种生物分子的高结合亲和力,这使得它们成为生物医学应用的合适候选物。在这里,我们报告了一种非免疫原性的光固化人血清(HSA)水凝胶,它是通过甲基丙烯酰化人血清白蛋白(HSA)与甲基丙烯酰酐(MAA)合成的。我们使用基质辅助激光解吸电离飞行时间质谱、液相色谱-串联质谱以及凝胶渗透色谱来评估甲基丙烯酰化白蛋白大分子和其交联水凝胶的修饰程度、水解和酶解降解程度。使用脑源性 HMC3 巨噬细胞和 Ex-Ovo 鸡胚绒毛尿囊膜分析评估了甲基丙烯酰化和交联对炎症反应和毒性改变的影响。结果表明,HSA 中的赖氨酸是与 MAA 反应的主要靶标,尽管 MAA 也修饰了半胱氨酸、苏氨酸、丝氨酸和酪氨酸。甲基丙烯酰化 HSA 及其衍生的水凝胶均无毒,不会诱导炎症途径,同时显著减少巨噬细胞对水凝胶的黏附;这是生物材料异物反应过程中的关键步骤之一。细胞因子和生长因子分析表明,基于白蛋白的水凝胶在 HMC3 巨噬细胞中表现出抗炎反应调节细胞事件。Ex-Ovo 结果也证实了 HSA 大分子和水凝胶的生物相容性以及轻微的血管生成调节作用。光固化白蛋白水凝胶可用作各种生物医学应用的非免疫原性平台,包括钝化涂层。